Cromos Pharma

Cromos Pharma Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and ex

cellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

Clinical trials are generating more data than ever, but more data does not mean better decisions. In this expert article...
04/30/2026

Clinical trials are generating more data than ever, but more data does not mean better decisions. In this expert article, Kristina Leus, Head of Biometrics at Cromos Pharma, shares practical lessons from 10+ years in clinical biometrics: from why database lock is just the beginning, to how poor data architecture can delay entire programs.

Real case studies. Real operational insights. And one clear message: success in clinical development depends on how well data is structured, interpreted, and translated into evidence.

Read more:https://cromospharma.com/from-data-to-decisions-lessons-from-10-years-in-clinical-biometrics/?preview=true

04/28/2026

We’re pleased to share that Vlad Bogin, MD, FACP will be attending the 2026 ASCO Annual Meeting, taking place May 29 – June 2, in Chicago, IL.

The ASCO Annual Meeting remains one of the most influential global gatherings in oncology, bringing together clinicians, researchers, and industry leaders to share the latest advances in cancer research and clinical development. The event offers a unique platform to discuss emerging therapeutic strategies, evolving clinical trial models, and the future of oncology care.

Vlad looks forward to connecting with peers, exchanging perspectives, and discussing how Cromos Pharma can support complex clinical development programs.

If you will be attending ASCO and would like to schedule a meeting, please reach out at inquiry@cromospharma.com

The FDA flagged 2,200+ sponsors over missing clinical trial results, with 3,000+ studies affected. This goes beyond comp...
04/24/2026

The FDA flagged 2,200+ sponsors over missing clinical trial results, with 3,000+ studies affected. This goes beyond compliance. As trial designs become more flexible, missing data becomes more visible and more impactful for how evidence is perceived. For sponsors, reporting is no longer just a final step. It is part of how programs are judged.

Read more: https://cromospharma.com/fda-flags-2-200-sponsors-over-missing-trial-results/

Pancreatic cancer has long been one of the most difficult areas in oncology, with limited progress and consistently poor...
04/21/2026

Pancreatic cancer has long been one of the most difficult areas in oncology, with limited progress and consistently poor outcomes.

New Phase 3 data with daraxonrasib changes that narrative, showing a near doubling of overall survival and challenging the long-standing belief that RAS is undruggable. This is not just incremental improvement, but a signal that a new therapeutic approach may be emerging.

Read more: https://cromospharma.com/a-breakthrough-in-one-of-the-deadliest-cancers-what-daraxonrasib-really-changes/

04/14/2026

What happens when sponsors finally get real clarity on trial costs, in minutes?

A few weeks ago, we introduced our AI-powered Clinical Trial Budget Calculator, a comprehensive tool designed to bring speed and transparency to early-stage trial planning, now available on our website: https://cromospharma.com/expertise/calculator/
It is already being actively used, and the feedback has been excellent. Teams are using it to align internally, compare multiple scenarios, and move early discussions forward with greater confidence.

This is exactly the gap we set out to solve.
The tool allows you to adjust key parameters in minutes, including countries, sites, enrollment targets, and timelines, and instantly see how your budget evolves across different scenarios. Built for early-stage planning, designed for real-world decision-making.
If you are shaping your study or exploring different setups, it is worth trying.

Explore it here: https://cromospharma.com/expertise/calculator/

We are pleased to share that our Türkiye Country Head, Cagla Akmemis, was invited as a speaker at the İstinye University...
04/09/2026

We are pleased to share that our Türkiye Country Head, Cagla Akmemis, was invited as a speaker at the İstinye University Career Days FutureX Summit held on April 8.

The discussion explored key shifts in clinical research, the growing impact of technology on the industry, and the skills that will shape the next generation of professionals.

Engaging with students and young professionals considering careers in clinical research and life sciences made this exchange particularly valuable.

At Cromos Pharma, supporting emerging talent and sharing practical industry insights remains a core part of how we contribute to the future of clinical research.

İstinye University continues to foster a strong platform where academia and industry connect and exchange knowledge.

We look forward to continuing this dialogue.

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research in 2026: – ...
04/07/2026

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research in 2026:

– AI Budget Planning: Cromos Pharma launches an AI-powered calculator to model trial scenarios and estimate costs in minutes for faster early decisions.
– Shift to Human-Based Research: The FDA and NIH are accelerating the move beyond animal testing, investing in organ-on-chip, in vitro, and AI-driven models.
– Nephrology Trials in Focus: Kidney research is gaining momentum with growing pipelines, evolving endpoints, and new opportunities in cardio-renal and rare diseases.

Read the full newsletter: https://cromospharma.com/clinical-research-focus-51st-edition/

04/03/2026

As Easter 2026 approaches, we at Cromos Pharma would like to share our warmest wishes with you and your loved ones.

May this season inspire renewed energy, good health, and continued success both personally and professionally.
Wishing you a joyful, peaceful, and meaningful celebration!

04/01/2026

Cromos Pharma is currently seeking a Clinical Project Manager to join our team.

Location: Europe

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/clinical-project-manager/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

03/31/2026

Warmest Passover greetings from everyone at Cromos Pharma!

May this meaningful season fill your days with joy, warmth, and time well spent with those who matter most. We celebrate the spirit of unity and resilience that Passover embodies.

Chag Sameach!

03/20/2026

Eid Mubarak!

As the holy month of Ramadan comes to an end, we extend our warmest wishes for peace, joy, and prosperity. May this special celebration bring happiness, unity, and blessings to you and your loved ones.

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share